A September 27 editorial in the New York Times calls on the US Congress to pass legislation that will force pharmaceutical companies to publicly disclose all payments they make to physicians. As the editorial puts it, “Patients need to know that doctors are prescribing particular drugs for sound medical reasons — not because drug companies have bought their doctors’ loyalty.”

The editorial follows an exposé the New York Times published this past July (see the AHP report) in which it was revealed that “nearly 1/3 of the [American Psychiatric Association’s] budget comes directly from the pharmaceutical industry, in the form of journal ads, convention exhibits, and the sponsoring of fellowships, conferences, and symposia.” Continue reading NYT: Law Should Compel Disclosure of Drug Company Payments to Physicians →